Proposed US bill could allow extensions on biologics patent terms

27-03-2014

Proposed US bill could allow extensions on biologics patent terms

Photo: Andrea Izzotti / Shutterstock.com

Three US lawmakers have introduced legislation that, if passed, would allow patent owners to obtain protection for existing biologic drugs that have been approved for new indications.


Independent Innovator and Repurposing Act, Congress, biologics, patent term extension, regulatory delay

LSIPR